These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32538267)

  • 1. Naltrexone during pain conditioning: A double-blind placebo-controlled experimental trial.
    Pontén M; Fust J; Kosek E; Guterstam J; Jensen K
    Mol Pain; 2020; 16():1744806920927625. PubMed ID: 32538267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of conditioned pain modulation in humans by naltrexone: an exploratory study of the effects of pain catastrophizing.
    King CD; Goodin B; Kindler LL; Caudle RM; Edwards RR; Gravenstein N; Riley JL; Fillingim RB
    J Behav Med; 2013 Jun; 36(3):315-27. PubMed ID: 22534819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study.
    Hamann S; Sloan P
    J Opioid Manag; 2007; 3(3):137-44. PubMed ID: 18027539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans.
    Courtney KE; Ghahremani DG; Ray LA
    Neuropsychopharmacology; 2016 Nov; 41(12):2872-2881. PubMed ID: 27312405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J; Noor N; McCue R; Mackey S
    Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems.
    Amanzio M; Benedetti F
    J Neurosci; 1999 Jan; 19(1):484-94. PubMed ID: 9870976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans.
    Weber SC; Beck-Schimmer B; Kajdi ME; Müller D; Tobler PN; Quednow BB
    Transl Psychiatry; 2016 Jul; 6(7):e850. PubMed ID: 27378550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain.
    Weil AJ; Masters ET; Barsdorf AI; Bass A; Pixton G; Wilson JG; Wolfram G
    Health Qual Life Outcomes; 2017 Oct; 15(1):202. PubMed ID: 29041942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study.
    Guterstam J; Jayaram-Lindström N; Berrebi J; Petrovic P; Ingvar M; Fransson P; Franck J
    Drug Alcohol Depend; 2018 Oct; 191():91-97. PubMed ID: 30096639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naltrexone on learning and performance of conditional fear-induced freezing and opioid analgesia.
    Helmstetter FJ; Fanselow MS
    Physiol Behav; 1987; 39(4):501-5. PubMed ID: 3575497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.
    Comer SD; Sullivan MA; Yu E; Rothenberg JL; Kleber HD; Kampman K; Dackis C; O'Brien CP
    Arch Gen Psychiatry; 2006 Feb; 63(2):210-8. PubMed ID: 16461865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operant and classical learning principles underlying mind-body interaction in pain modulation: a pilot fMRI study.
    Lee IS; Jung WM; Lee YS; Wallraven C; Chae Y
    Sci Rep; 2021 Jan; 11(1):1663. PubMed ID: 33462278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological fMRI provides evidence for opioidergic modulation of discrimination of facial pain expressions.
    Zhao Y; Rütgen M; Zhang L; Lamm C
    Psychophysiology; 2021 Feb; 58(2):e13717. PubMed ID: 33140886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging.
    Mann K; Vollstädt-Klein S; Reinhard I; Leménager T; Fauth-Bühler M; Hermann D; Hoffmann S; Zimmermann US; Kiefer F; Heinz A; Smolka MN
    Alcohol Clin Exp Res; 2014 Nov; 38(11):2754-62. PubMed ID: 25421512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription opioid misusing chronic pain patients exhibit dysregulated context-dependent associations: Investigating associative learning in addiction with the cue-primed reactivity task.
    Garland EL; Bryan CJ; Kreighbaum L; Nakamura Y; Howard MO; Froeliger B
    Drug Alcohol Depend; 2018 Jun; 187():13-21. PubMed ID: 29626741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.
    Hyman SM; Fox H; Hong KI; Doebrick C; Sinha R
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):134-43. PubMed ID: 17469937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and central correlates of contextual fear learning and contextual modulation of cued fear in posttraumatic stress disorder.
    Steiger F; Nees F; Wicking M; Lang S; Flor H
    Int J Psychophysiol; 2015 Dec; 98(3 Pt 2):584-93. PubMed ID: 26149734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaternary naltrexone reveals the central mediation of conditional opioid analgesia.
    Calcagnetti DJ; Helmstetter FJ; Fanselow MS
    Pharmacol Biochem Behav; 1987 Jul; 27(3):529-31. PubMed ID: 2821555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients.
    Langleben DD; Ruparel K; Elman I; Loughead JW; Busch EL; Cornish J; Lynch KG; Nuwayser ES; Childress AR; O'Brien CP
    Addict Biol; 2014 Mar; 19(2):262-71. PubMed ID: 22747521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.